Rodrìguez-Tajes et al. [28] investigated 600 COVID-19 patients, of which data on HBV infection was available in 484, and of whom 69 (14%) screened HBsAg-negative, anti-HBc-positive, and HBV DNA undetectable. Here, KRT88P is linked to COVID-19.